Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05323383

The Effects and Mechanisms of Brief Mindfulness Meditation and Hypnosis for Pain

The Effects and Mechanisms of Brief Training in Mindfulness Meditation and Hypnosis for Pain Management, Relative to an Inert Control

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
The University of Queensland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the effects and mechanisms of 1 x 20-min training in mindfulness meditation and self-hypnosis relative to an inert control. Participants will be randomly assigned to condition. The dual primary outcomes will be pre- to post-training changes in current pain intensity and pain unpleasantness. The active treatments are hypothesized to produce greater reductions in pain outcomes than the control. It is also hypothesized that change in mindfulness will be a mediator specific to mindfulness meditation, while change in affect and decentering will be mediators of the hypnosis condition. Moderators of response will also be explored.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness MeditationParticipants in the mindfulness meditation condition will listen to a 20minute guided mindfulness meditation practice that holds the breath and body as the object of meditation.
BEHAVIORALSelf-hypnosisParticipants in self-hypnosis will listen to a 20-minute audio-guided hypnosis practice with an induction phase, followed by suggestions tailored towards shifts in affect and decentering, and then a re-alerting with post-hypnotic suggestions phase.
OTHERAttention ControlControl participants will listen to a 20-minute natural history recording which was chosen as past research has found that individuals who listen to it report this to be a neutral, but relaxing passage, and it has been used as an effective control condition in previous research.

Timeline

Start date
2022-03-24
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2022-04-12
Last updated
2024-09-27

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05323383. Inclusion in this directory is not an endorsement.